Efficacy and safety of 3 agomelatine dose regimens (10, 25, 25-50 mg) versus placebo in out-patients suffering from moderate to severe major depressive disorder

Authors
Category Primary study
JournalEuropean Psychiatry
Year 2013
This article has no abstract
Epistemonikos ID: 21dfeab3a0c5c948f2f8bdcb853ac905fd5be680
First added on: Feb 05, 2025